Diabetes practices emerge from the COVID-19 pandemic
Rely on Atellica DCA Analyzer to optimize your in-office POC diabetes testing
With many point-of-care HbA1c testing facilities closing their doors due to the COVID-19 pandemic, many people living with diabetes were unable to have their HbA1c tested. A full year of uncontrolled diabetes is not benign and could affect life expectancy.1 Let’s get patients back to the point of care and provide important HbA1c testing.
Point-of-care testing has proven more effective in reducing HbA1c than other testing methods. Face-to-face counseling enables education, helps to engage patients, and leads to increased compliance.
The Atellica DCA Analyzer is a compact, portable, and fully customizable POC diabetes testing system that puts fast, quality results right at your fingertips.
A simplified user interface can minimize training time and provide patients with timely test results
Click here to explore how Atellica DCA Analyzer2 can help you optimize your point-of-care HbA1c testing
https://www.wsj.com/articles/the-consequences-of-skipping-doctor-appointments-during-the-covid-pandemic-11620067142?st=f792pgmxbtf27vf&reflink=article_email_share
Not available for sale in the U.S. Product availability varies by country.